Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours
Article in Cancer Immunology, Immunotherapy (March 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Cancer Immunology, Immunotherapy (March 2024)
Article in American Journal of Clinical Oncology (February 2024)
Article in Medicine (November 2023)